LYNX1 CAPITAL MANAGEMENT LP purchased 4.2% of their position (373.64K shares) of PASSAGE BIO, INC. on the open market
Open‑market purchase worth $241.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/31/2024ACC: 0000902664-24-007075
10% Owner
Since Aug 2024
+373.64K
Net shares
Net buyer
$241.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
373.64K acquired
Non-Derivative Transactions1
Common stock, $0.0001 par value per share
Indirect
Shares
+373.64K
Price / share
$0.65
Trade value
$241.04K
% of position
4.2%
12/27/2024
8.88M→9.26M
Total
Net shares
+373.64K
Net value
$241.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.0001 par value per share Indirect | 12/27/2024 | P · Purchase | +373.64K | $0.65 | $241.04K | 4.2% | 8.88M | 9.26M |
| Total | +373.64K | $241.04K | ||||||
Derivative Transactions0
No derivative transactions reported